SCHEMBL4034392

SCHEMBL4034392

CCN(CC)[C@H](C(=O)N1CCCC1c1ncc(-c2ccc(-c3ncc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)O)C(C)C)[nH]4)cn3)cc2)[nH]1)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.70
CYP3A4 P08684 4/20 0.58
CYP2C9 P11712 3/20 0.58
NR1I2 O75469 2/20 0.58
ABCB11 O95342 1/20 0.58
OPRK1 P41145 1/20 0.58
CYP1A2 P05177 2/20 0.55
CYP2D6 P10635 1/20 0.53
PRCP P42785 6/20 0.46
OPRM1 P35372 2/20 0.46
OPRD1 P41143 2/20 0.46
HPGDS O60760 1/20 0.41
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3349690 1.00 KCNH2 (0.70) KCNH2CYP3A4CYP2C9NR1I2ABCB11
SCHEMBL3343647 0.95 KCNH2 (0.77) KCNH2CYP3A4CYP2C9NR1I2ABCB11
SCHEMBL2586063 0.94 KCNH2 (0.78) KCNH2CYP3A4CYP2C9NR1I2ABCB11
SCHEMBL3090060 0.93 KCNH2 (0.79) KCNH2CYP3A4CYP2C9NR1I2ABCB11
SCHEMBL692686 0.90 KCNH2 (0.74) KCNH2CYP3A4CYP2C9NR1I2ABCB11
SCHEMBL6127044 0.90 KCNH2 (0.70) KCNH2CYP3A4CYP2C9NR1I2ABCB11
SCHEMBL15406422 0.90 KCNH2 (0.70) KCNH2CYP3A4CYP2C9NR1I2ABCB11
SCHEMBL16105905 0.90 KCNH2 (0.66) KCNH2CYP3A4CYP2C9NR1I2ABCB11
SCHEMBL19548079 0.90 KCNH2 (0.71) KCNH2CYP3A4CYP2C9NR1I2ABCB11
SCHEMBL690397 0.90 KCNH2 (0.71) KCNH2CYP3A4CYP2C9NR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049116-A2 HEPATITIS C VIRUS INHIBITORS Brystol-Myers Squibb Company (US) 2009-04-22 EP claimed
WO-2008021928-A2 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 WO claimed